Transcription of APO-AZITHROMYCIN - Medsafe
{{id}} {{{paragraph}}}
NEW ZEALAND DATA SHEET APO-AZITHROMYCIN Please refer to Medsafe website ( ) for the most recent datasheet Page 1 of 21 1. APO-AZITHROMYCIN (250mg and 500mg tablets) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION azithromycin 250mg and 500mg (as dihydrate) Excipient(s) of known effect APO-AZITHROMYCIN does not contain gluten or lactose. For a full list of excipients, see section 3. PHARMACEUTICAL FORM APO-AZITHROMYCIN 250mg tablets are white, oval, film coated tablets embossed AZ250 one side and APO on the other. Each tablet contains azithromycin dihydrate equivalent to azithromycin 250mg. APO-AZITHROMYCIN 500mg tablets are white, oval, film coated tablets embossed AZ500 one side and APO on the other. Each tablet contains azithromycin dihydrate equivalent to azithromycin 500mg. 4. CLINICAL PARTICULARS Therapeutic indications azithromycin is indicated for use in adults for the treatment of the following infections of mild to moderate severity: 1.
APO-AZITHROMYCIN Please refer to Medsafe website (www.medsafe.govt.nz) for the most recent datasheet Page 2 of 21 Acute streptococcal pharyngitis.Note: Penicillin is the usual drug of choice in the
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}